| Literature DB >> 23897858 |
Karen L Price1, H Amy Xia, Mani Lakshminarayanan, David Madigan, David Manner, John Scott, James D Stamey, Laura Thompson.
Abstract
Safety assessment is essential throughout medical product development. There has been increased awareness of the importance of safety trials recently, in part due to recent US Food and Drug Administration guidance related to thorough assessment of cardiovascular risk in the treatment of type 2 diabetes. Bayesian methods provide great promise for improving the conduct of safety trials. In this paper, the safety subteam of the Drug Information Association Bayesian Scientific Working Group evaluates challenges associated with current methods for designing and analyzing safety trials and provides an overview of several suggested Bayesian opportunities that may increase efficiency of safety trials along with relevant case examples.Entities:
Keywords: Bayesian safety trials; hierarchical modeling; medical product safety; outcomes trials; postmarketing safety surveillance; rare events
Mesh:
Year: 2013 PMID: 23897858 DOI: 10.1002/pst.1586
Source DB: PubMed Journal: Pharm Stat ISSN: 1539-1604 Impact factor: 1.894